Name | Number of supported studies | Average coverage | |
---|---|---|---|
dendritic cell | 4 studies | 20% ± 5% |
Insufficient scRNA-seq data for expression of GPR132 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 99% | 461.99 | 575 / 578 | 83% | 6.71 | 959 / 1155 |
kidney | 99% | 353.30 | 88 / 89 | 81% | 5.14 | 728 / 901 |
breast | 90% | 161.78 | 412 / 459 | 84% | 6.00 | 944 / 1118 |
thymus | 98% | 642.23 | 637 / 653 | 76% | 5.36 | 462 / 605 |
intestine | 92% | 292.50 | 893 / 966 | 66% | 3.42 | 347 / 527 |
bladder | 90% | 114.76 | 19 / 21 | 64% | 3.88 | 323 / 504 |
stomach | 79% | 112.18 | 283 / 359 | 74% | 3.75 | 213 / 286 |
uterus | 76% | 97.11 | 129 / 170 | 75% | 5.05 | 346 / 459 |
esophagus | 80% | 111.45 | 1161 / 1445 | 67% | 3.83 | 122 / 183 |
skin | 72% | 188.75 | 1298 / 1809 | 61% | 3.90 | 290 / 472 |
ovary | 35% | 36.67 | 63 / 180 | 73% | 4.53 | 316 / 430 |
pancreas | 19% | 19.15 | 62 / 328 | 88% | 9.20 | 157 / 178 |
prostate | 85% | 138.84 | 209 / 245 | 22% | 0.78 | 109 / 502 |
brain | 55% | 61.56 | 1450 / 2642 | 47% | 2.05 | 334 / 705 |
lymph node | 0% | 0 | 0 / 0 | 100% | 21.02 | 29 / 29 |
spleen | 100% | 1233.96 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 2230.14 | 928 / 929 | 0% | 0 | 0 / 0 |
adipose | 96% | 278.07 | 1153 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 78% | 101.43 | 202 / 258 | 7% | 0.26 | 15 / 230 |
tonsil | 0% | 0 | 0 / 0 | 78% | 5.86 | 35 / 45 |
blood vessel | 64% | 111.58 | 852 / 1335 | 0% | 0 | 0 / 0 |
heart | 44% | 47.77 | 383 / 861 | 0% | 0 | 0 / 0 |
liver | 20% | 18.94 | 46 / 226 | 20% | 0.96 | 80 / 406 |
eye | 0% | 0 | 0 / 0 | 8% | 0.26 | 6 / 80 |
muscle | 6% | 6.04 | 51 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0010972 | Biological process | negative regulation of G2/M transition of mitotic cell cycle |
GO_0000082 | Biological process | G1/S transition of mitotic cell cycle |
GO_0005886 | Cellular component | plasma membrane |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
Gene name | GPR132 |
Protein name | G protein-coupled receptor 132 Truncated G protein-coupled receptor 132 Probable G-protein coupled receptor 132 (G2 accumulation protein) |
Synonyms | G2A |
Description | FUNCTION: May be a receptor for oxidized free fatty acids derived from linoleic and arachidonic acids such as 9-hydroxyoctadecadienoic acid (9-HODE). Activates a G alpha protein, most likely G alpha(q). May be involved in apoptosis. Functions at the G2/M checkpoint to delay mitosis. May function as a sensor that monitors the oxidative states and mediates appropriate cellular responses such as secretion of paracrine signals and attenuation of proliferation. May mediate ths accumulation of intracellular inositol phosphates at acidic pH through proton-sensing activity. . |
Accessions | B2LM89 ENST00000329797.8 [Q9UNW8-1] ENST00000392585.2 [Q9UNW8-3] ENST00000551869.1 F8VRH8 ENST00000549990.1 ENST00000539291.6 [Q9UNW8-1] A0A0G2JL29 Q9UNW8 |